INSR and Alzheimer disease: Using different experimental models of AD, ranging from hippocampal cell cultures to mice to non-human primates (NHPs), Batista et al. describe how liraglutide prevents the loss of brain insulin receptors and synapses by activation of the PKA signaling pathway [166].